Literature DB >> 18049104

Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation.

Joanna Ashton-Chess1, Magali Giral, Sophie Brouard, Jean-Paul Soulillou.   

Abstract

Tolerance is the so-called "Holy Grail" of transplantation, but achieving this state is proving a major challenge, particularly in the clinical setting. Even in rodents, the definition of true transplant tolerance is not applicable to many models, with late graft damage often occurring despite long-term graft survival. Hence the term "operational tolerance," based more on graft function and absence of exogenous immunosuppression, is being adopted. Although the most sought-after goal in this field is to intentionally induce this state in a controlled manner, translating protocols across species from rodents to the clinic, the current literature demonstrates that this is proving a formidable task. A complementary approach is to address transplant tolerance from a different angle, by studying tolerance-like phenomena that occur "unintentionally" in transplant patients after immunosuppressive drug weaning. Such spontaneous operational tolerance, which can take place after years of immunosuppression, is rare in kidney transplant recipients. However, determining exactly how this state arises and how it can be detected may make it possible to induce it in a greater number of patients and then to return to the drawing board to rationally design protocols that have a greater chance of clinical success. Moreover, the study of such patients should help in the identification of biomarkers of low immunological risk that could be used to select patients for potential weaning. Collaborative efforts through international networks, together with the application of newer and more powerful technologies to diagnostic, prognostic, and mechanistic research, may help transplanters to achieve this goal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18049104     DOI: 10.1097/01.tp.0000290683.54937.1b

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  24 in total

1.  Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant.

Authors:  Richard Danger; Annaïck Pallier; Magali Giral; Marc Martínez-Llordella; Juan José Lozano; Nicolas Degauque; Alberto Sanchez-Fueyo; Jean-Paul Soulillou; Sophie Brouard
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 2.  Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.

Authors:  Alberto Sánchez-Fueyo; Terry B Strom
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

3.  Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model.

Authors:  T Wang; E B Ahmed; L Chen; J Xu; J Tao; C-R Wang; M-L Alegre; A S Chong
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

4.  Facilitating cells: Translation of hematopoietic chimerism to achieve clinical tolerance.

Authors:  Suzanne T Ildstad; Joseph Leventhal; Yujie Wen; Esma Yolcu
Journal:  Chimerism       Date:  2016-01-08

Review 5.  Towards the identification of biomarkers of transplantation tolerance.

Authors:  Laurence A Turka; Robert I Lechler
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

Review 6.  Tolerance--is it worth it?

Authors:  Erik B Finger; Terry B Strom; Arthur J Matas
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

Review 7.  Updated follow-up of a tolerance protocol in HLA-identical renal transplant pairs given donor hematopoietic stem cells.

Authors:  Joseph R Leventhal; Joshua Miller; James M Mathew; Sunil Kurian; Anat R Tambur; John Friedewald; Jane Charrette; Michael M Abecassis
Journal:  Hum Immunol       Date:  2018-02-01       Impact factor: 2.850

Review 8.  Bacterial infections, alloimmunity, and transplantation tolerance.

Authors:  Emily B Ahmed; Melvin Daniels; Maria-Luisa Alegre; Anita S Chong
Journal:  Transplant Rev (Orlando)       Date:  2011-01       Impact factor: 3.943

Review 9.  Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection?

Authors:  Roberta Angelico; Alessandro Parente; Tommaso Maria Manzia
Journal:  Transl Gastroenterol Hepatol       Date:  2017-09-21

Review 10.  Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.

Authors:  Dela Golshayan; Manuel Pascual
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.